Connect with us

Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021

Reopening penny stocks are showing momentum right now; here’s 6 to watch
The post Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Published

on

Are Reopening Penny Stocks Worth it For Your July Watchlist?

Reopening penny stocks have remained some of the hottest choices for all types of investors in 2021. Before we go any further, it’s worth understanding what they are in order to know how to use them to your advantage.

When the pandemic first began, most stocks, penny stocks included, declined rapidly in value. This made sense as economies were responding to there extraordinary situation that the world was put in. However very quickly, companies that were able to benefit, began to do just that. This results in many penny stocks and blue chips, shooting up in value. For example, this includes biotech penny stocks, retail penny stocks, and many more.

[Read More] Top Mining Penny Stocks to Buy Right Now? 4 to Watch in 2021

But now, a year and a half after the pandemic began, many thought that we were out of the woods. However, with the Delta variant on the rise, we could be entering another wave of Covid-19. While this may seem disheartening, there are plenty of ways to benefit from the pandemic and whether or not it continues to wreak havoc. This includes reopening penny stocks.

The term itself is quite a loose definition, and allows for many different stocks to be considered. But, investors need to understand exactly how a company on their list of penny stocks, will benefit from the pandemic. This is not easy, and involves a great deal of research and commitment. So, with all of this in mind, here are six reopening penny stocks to watch right now. 

6 Reopening Penny Stocks to Watch in Summer 2021

  1. Ashford Hospitality Trust Inc. (NYSE: AHT
  2. Globalstar Inc. (NYSE: GSAT
  3. Aerpio Pharmaceuticals Inc. (NASDAQ: ARPO
  4. Ambev S.A. (NYSE: ABEV
  5. Advaxis Inc. (NASDAQ: ADXS
  6. Sonim Technologies Inc. (NASDAQ: SONM

Ashford Hospitality Trust Inc. (NYSE: AHT)

Ashford Hospitality Trust Inc. is a penny stock that has had an interesting year in 2021. The company operates as a real estate investment trust that invests in upscale full-service hotels.

At the start of 2021, the company was at $2.40 per share on average. During one time period from May to June, the company’s stock price skyrocketed to nearly $7 per share on average. Then, its stock price fell back down to where around the $2.20 mark. On July 6th, Ashford announced its preliminary RevPAR results for the second quarter of the year. Its RevPAR increase was at 256% higher since June 2020.

“I am pleased to report these improved preliminary RevPAR results for the second quarter which are driven by pent-up leisure demand. We continue to be pleased with the recovery trends we are seeing at our hotels, and with our geographically diverse portfolio with high exposure to transient leisure customers, we believe we are well-positioned to capitalize on this recovery.”

President and CEO of AHT, Rob Hays

The real estate market is booming right now, and property values continue to skyrocket. With this in mind, AHT stock could be an interesting company to keep an eye on.

Globalstar Inc. (NYSE: GSAT)

Globalstar Inc. is a penny stock that provides mobile satellite services and off-grid communication offerings. This includes mobile voice and data satellite services. These products are in use for emergencies, safety, recreation, business, and more.

Its SPOT consumer retail products such as the SPOT Trace anti-theft and item tracker have become very popular among consumers, highlighting Globalstar’s overall product line. And, its website had 745,000 subscribers as of December 31st, 2020, which is quite a sizable number. On July 1st, the company announced a new partnership with FocusPoint International Inc. This partnership will give added benefits to Globalstar and SPOT customers.

“We are so pleased to extend this valuable service to Globalstar customers. Many of our users partake in extreme sports and engage in higher than average travel frequency making this offering a service that can help further improve our customers’ peace of mind. FocusPoint provides a comprehensive risk consulting service that is a great compliment to the connectivity we provide our customers.”

The CEO of Globalstar, David Kagan

This announcement was made on the first day of this month, and since then GSAT stock has increased in value. The one-month growth of GSAT stock is impressive for investors to consider. In mid-June, the company was at $1.30 per share on average, and now GSAT is at $1.79 per share as as of mid-July. With this in mind, will GSAT stock be on your list of penny stocks to watch this week?

Penny_Stocks_to_Watch_Globalstar_Inc._(GSAT_Stock_Chart)

Aerpio Pharmaceuticals Inc. (NASDAQ: ARPO)

Aerpio Pharmaceuticals Inc. is a biotech penny stock that is witnessing solid bullish momentum right now. The company develops and commercializes compounds that activate Tie2 receptors to treat ocular disease and vascular stabilization. One of Aerpio’s main products is razuprotafib, which is in Phase 2b trials to treat non-proliferative diabetic retinopathy.

On June 4th, the latest update from this biotech penny stock was released. Aadi Bioscience Inc. announced at the ASCO 2021 Virtual Meeting that Aerpio has entered an agreement and Plan of Merger with itself, Aadi, and Aspen Merger Subsidiary Inc.

Despite no other recent company-specific updates, ARPO stock is skyrocketing in the market. 5 days ago, ARPO stock was worth $1.71 per share on average. Now ARPO stock price is at $2.56 per share on July 12th. With this in mind, is ARPO stock worth watching?

Penny_Stocks_to_Watch_Aerpio_Pharmaceuticals_Inc_ARPO_Stock_Chart

Ambev S.A. (NYSE: ABEV)

Ambev S.A. is a penny stock that sells beer, soft drinks, and a long list of other beverages as well. Some of its beer brands include Budweiser, Bud Light, Stella Artois, and Corona. Its other beverage products include Pepsi, Seven Up, Lipton, and many more. These products are offered via third-party distribution and direct distribution in the Americas.

[Read More] Hot Penny Stocks to Buy Right Now? 3 For Your July Watchlist

On June 9th, Ambev backed away from Copa America as a sponsor because of players’ unrest about COVID-19 concerns. Apart from this recent update, the company has not released any news. Despite this, its stock price is increasing a lot. ABEV stock has gone up by more than 14% in 2021 so far. 

At one point earlier this year, the company’s stock price was up 30%, in 2021, before dropping silghtly. Now the company has grown to have an average volume of more than 24 million. ABEV stock also increased by 1.49% on the day of July 12th, which is worth noting. Whether this makes ABEV stock a part of your watchlist this week is up to you. 

Penny_Stocks_to_Watch_Ambev_S.A._(ABEV_Stock_Chart)

Advaxis Inc. (NASDAQ: ADXS)

Advaxis Inc. is a biotech penny stock that operates in the United States. The company discovers, develops, and commercializes medical tech products. Its main product uses Listeria monoxytogens tech antigens for drug delivery purposes. Additionally its compound, ADXS-PSA trial is in Phase 2 for treating metastatic prostate cancer. Advaxis is also developing a variety of other products for the treatment of cancer.

On July 6th, Advaxis and Biosight Therapeutics announced that they have entered a definitive merger agreement. The combined company will operate as Biosight Therapeutics. This will help advance its pipeline of programs. The combined company will also be well-funded with a cash position of about $50 million. 

“We believe the combined company’s strong and diversified oncology pipeline with late-stage and early-stage assets, near-term milestones, seasoned leadership team and focus on both hematological malignancies and solid tumors have the potential to provide transformative benefits to patients while also providing value to our stockholders.”

The President, CEO, and CFO of Advaxis

ADXS stock experienced a huge spike on the day of this announcement, but it quickly corrected, as most large jumps do. Now on July 12th, the company’s stock price is up 0.31% in the market. With the above information in mind, will ADXS be on your list of penny stocks to watch?

Penny_Stocks_to_Watch_Advaxis_Inc

Sonim Technologies Inc. (NASDAQ: SONM)

This next penny stock to watch, Sonim Technologies Inc., is quite popular among retail investors right now. Sonim provides tough-built mobile phones for public and private networks. Its products include the Sonim XP5s, Sonim XP3, and Sonim XP8. These products are sold to companies involved in construction, manufacturing, energy, and more.

On June 30th, the company announced the launch of its RT80 rugged tablet. The tablet is designed for industrial, field service, and public safety workers. The CMO of Sonim, John Graff said, “The RT80’s purpose-built durable design can provide better total cost of ownership than consumer tablets where customers suffer increased downtime due to the inability to withstand the rigors of many work environments.”

SONM stock has not had the best year, with several ups and downs in its stock price so far. But, could things be changing for the tech penny stock? On July 12th, SONM stock shot up by around 5% in the market. On the same day, its volume is more than 3.6 times its market average. With this recent momentum in mind, will you add SONM to your penny stock watchlist?

Penny_Stocks_to_Watch_Sonim_Technologies_Inc_SONM_Stock_Chart

Are Reopening Penny Stocks Worth it or Not?

Finding the best reopening penny stocks is all about understanding just how a company will be affected by the pandemic. This involves researching what it does, how it may benefit from increased case numbers, and what its fundamentals look like.

[Read More] Best Penny Stocks To Buy Before Marijuana Legalization? 4 To Watch Now

While it may seem difficult off the bat, with enough information on hand, it can be easy to find valuable penny stocks to watch. So, with everything considered, what do you think? Are reopening penny stocks worth it or not?

The post Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

Continue Reading

International

Beloved mall retailer files Chapter 7 bankruptcy, will liquidate

The struggling chain has given up the fight and will close hundreds of stores around the world.

Published

on

It has been a brutal period for several popular retailers. The fallout from the covid pandemic and a challenging economic environment have pushed numerous chains into bankruptcy with Tuesday Morning, Christmas Tree Shops, and Bed Bath & Beyond all moving from Chapter 11 to Chapter 7 bankruptcy liquidation.

In all three of those cases, the companies faced clear financial pressures that led to inventory problems and vendors demanding faster, or even upfront payment. That creates a sort of inevitability.

Related: Beloved retailer finds life after bankruptcy, new famous owner

When a retailer faces financial pressure it sets off a cycle where vendors become wary of selling them items. That leads to barren shelves and no ability for the chain to sell its way out of its financial problems. 

Once that happens bankruptcy generally becomes the only option. Sometimes that means a Chapter 11 filing which gives the company a chance to negotiate with its creditors. In some cases, deals can be worked out where vendors extend longer terms or even forgive some debts, and banks offer an extension of loan terms.

In other cases, new funding can be secured which assuages vendor concerns or the company might be taken over by its vendors. Sometimes, as was the case with David's Bridal, a new owner steps in, adds new money, and makes deals with creditors in order to give the company a new lease on life.

It's rare that a retailer moves directly into Chapter 7 bankruptcy and decides to liquidate without trying to find a new source of funding.

Mall traffic has varied depending upon the type of mall.

Image source: Getty Images

The Body Shop has bad news for customers  

The Body Shop has been in a very public fight for survival. Fears began when the company closed half of its locations in the United Kingdom. That was followed by a bankruptcy-style filing in Canada and an abrupt closure of its U.S. stores on March 4.

"The Canadian subsidiary of the global beauty and cosmetics brand announced it has started restructuring proceedings by filing a Notice of Intention (NOI) to Make a Proposal pursuant to the Bankruptcy and Insolvency Act (Canada). In the same release, the company said that, as of March 1, 2024, The Body Shop US Limited has ceased operations," Chain Store Age reported.

A message on the company's U.S. website shared a simple message that does not appear to be the entire story.

"We're currently undergoing planned maintenance, but don't worry we're due to be back online soon."

That same message is still on the company's website, but a new filing makes it clear that the site is not down for maintenance, it's down for good.

The Body Shop files for Chapter 7 bankruptcy

While the future appeared bleak for The Body Shop, fans of the brand held out hope that a savior would step in. That's not going to be the case. 

The Body Shop filed for Chapter 7 bankruptcy in the United States.

"The US arm of the ethical cosmetics group has ceased trading at its 50 outlets. On Saturday (March 9), it filed for Chapter 7 insolvency, under which assets are sold off to clear debts, putting about 400 jobs at risk including those in a distribution center that still holds millions of dollars worth of stock," The Guardian reported.

After its closure in the United States, the survival of the brand remains very much in doubt. About half of the chain's stores in the United Kingdom remain open along with its Australian stores. 

The future of those stores remains very much in doubt and the chain has shared that it needs new funding in order for them to continue operating.

The Body Shop did not respond to a request for comment from TheStreet.   

Read More

Continue Reading

Government

Are Voters Recoiling Against Disorder?

Are Voters Recoiling Against Disorder?

Authored by Michael Barone via The Epoch Times (emphasis ours),

The headlines coming out of the Super…

Published

on

Are Voters Recoiling Against Disorder?

Authored by Michael Barone via The Epoch Times (emphasis ours),

The headlines coming out of the Super Tuesday primaries have got it right. Barring cataclysmic changes, Donald Trump and Joe Biden will be the Republican and Democratic nominees for president in 2024.

(Left) President Joe Biden delivers remarks on canceling student debt at Culver City Julian Dixon Library in Culver City, Calif., on Feb. 21, 2024. (Right) Republican presidential candidate and former U.S. President Donald Trump stands on stage during a campaign event at Big League Dreams Las Vegas in Las Vegas, Nev., on Jan. 27, 2024. (Mario Tama/Getty Images; David Becker/Getty Images)

With Nikki Haley’s withdrawal, there will be no more significantly contested primaries or caucuses—the earliest both parties’ races have been over since something like the current primary-dominated system was put in place in 1972.

The primary results have spotlighted some of both nominees’ weaknesses.

Donald Trump lost high-income, high-educated constituencies, including the entire metro area—aka the Swamp. Many but by no means all Haley votes there were cast by Biden Democrats. Mr. Trump can’t afford to lose too many of the others in target states like Pennsylvania and Michigan.

Majorities and large minorities of voters in overwhelmingly Latino counties in Texas’s Rio Grande Valley and some in Houston voted against Joe Biden, and even more against Senate nominee Rep. Colin Allred (D-Texas).

Returns from Hispanic precincts in New Hampshire and Massachusetts show the same thing. Mr. Biden can’t afford to lose too many Latino votes in target states like Arizona and Georgia.

When Mr. Trump rode down that escalator in 2015, commentators assumed he’d repel Latinos. Instead, Latino voters nationally, and especially the closest eyewitnesses of Biden’s open-border policy, have been trending heavily Republican.

High-income liberal Democrats may sport lawn signs proclaiming, “In this house, we believe ... no human is illegal.” The logical consequence of that belief is an open border. But modest-income folks in border counties know that flows of illegal immigrants result in disorder, disease, and crime.

There is plenty of impatience with increased disorder in election returns below the presidential level. Consider Los Angeles County, America’s largest county, with nearly 10 million people, more people than 40 of the 50 states. It voted 71 percent for Mr. Biden in 2020.

Current returns show county District Attorney George Gascon winning only 21 percent of the vote in the nonpartisan primary. He’ll apparently face Republican Nathan Hochman, a critic of his liberal policies, in November.

Gascon, elected after the May 2020 death of counterfeit-passing suspect George Floyd in Minneapolis, is one of many county prosecutors supported by billionaire George Soros. His policies include not charging juveniles as adults, not seeking higher penalties for gang membership or use of firearms, and bringing fewer misdemeanor cases.

The predictable result has been increased car thefts, burglaries, and personal robberies. Some 120 assistant district attorneys have left the office, and there’s a backlog of 10,000 unprosecuted cases.

More than a dozen other Soros-backed and similarly liberal prosecutors have faced strong opposition or have left office.

St. Louis prosecutor Kim Gardner resigned last May amid lawsuits seeking her removal, Milwaukee’s John Chisholm retired in January, and Baltimore’s Marilyn Mosby was defeated in July 2022 and convicted of perjury in September 2023. Last November, Loudoun County, Virginia, voters (62 percent Biden) ousted liberal Buta Biberaj, who declined to prosecute a transgender student for assault, and in June 2022 voters in San Francisco (85 percent Biden) recalled famed radical Chesa Boudin.

Similarly, this Tuesday, voters in San Francisco passed ballot measures strengthening police powers and requiring treatment of drug-addicted welfare recipients.

In retrospect, it appears the Floyd video, appearing after three months of COVID-19 confinement, sparked a frenzied, even crazed reaction, especially among the highly educated and articulate. One fatal incident was seen as proof that America’s “systemic racism” was worse than ever and that police forces should be defunded and perhaps abolished.

2020 was “the year America went crazy,” I wrote in January 2021, a year in which police funding was actually cut by Democrats in New York, Los Angeles, San Francisco, Seattle, and Denver. A year in which young New York Times (NYT) staffers claimed they were endangered by the publication of Sen. Tom Cotton’s (R-Ark.) opinion article advocating calling in military forces if necessary to stop rioting, as had been done in Detroit in 1967 and Los Angeles in 1992. A craven NYT publisher even fired the editorial page editor for running the article.

Evidence of visible and tangible discontent with increasing violence and its consequences—barren and locked shelves in Manhattan chain drugstores, skyrocketing carjackings in Washington, D.C.—is as unmistakable in polls and election results as it is in daily life in large metropolitan areas. Maybe 2024 will turn out to be the year even liberal America stopped acting crazy.

Chaos and disorder work against incumbents, as they did in 1968 when Democrats saw their party’s popular vote fall from 61 percent to 43 percent.

Views expressed in this article are opinions of the author and do not necessarily reflect the views of The Epoch Times or ZeroHedge.

Tyler Durden Sat, 03/09/2024 - 23:20

Read More

Continue Reading

Government

Veterans Affairs Kept COVID-19 Vaccine Mandate In Place Without Evidence

Veterans Affairs Kept COVID-19 Vaccine Mandate In Place Without Evidence

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

The…

Published

on

Veterans Affairs Kept COVID-19 Vaccine Mandate In Place Without Evidence

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

The U.S. Department of Veterans Affairs (VA) reviewed no data when deciding in 2023 to keep its COVID-19 vaccine mandate in place.

Doses of a COVID-19 vaccine in Washington in a file image. (Jacquelyn Martin/Pool/AFP via Getty Images)

VA Secretary Denis McDonough said on May 1, 2023, that the end of many other federal mandates “will not impact current policies at the Department of Veterans Affairs.”

He said the mandate was remaining for VA health care personnel “to ensure the safety of veterans and our colleagues.”

Mr. McDonough did not cite any studies or other data. A VA spokesperson declined to provide any data that was reviewed when deciding not to rescind the mandate. The Epoch Times submitted a Freedom of Information Act for “all documents outlining which data was relied upon when establishing the mandate when deciding to keep the mandate in place.”

The agency searched for such data and did not find any.

The VA does not even attempt to justify its policies with science, because it can’t,” Leslie Manookian, president and founder of the Health Freedom Defense Fund, told The Epoch Times.

“The VA just trusts that the process and cost of challenging its unfounded policies is so onerous, most people are dissuaded from even trying,” she added.

The VA’s mandate remains in place to this day.

The VA’s website claims that vaccines “help protect you from getting severe illness” and “offer good protection against most COVID-19 variants,” pointing in part to observational data from the U.S. Centers for Disease Control and Prevention (CDC) that estimate the vaccines provide poor protection against symptomatic infection and transient shielding against hospitalization.

There have also been increasing concerns among outside scientists about confirmed side effects like heart inflammation—the VA hid a safety signal it detected for the inflammation—and possible side effects such as tinnitus, which shift the benefit-risk calculus.

President Joe Biden imposed a slate of COVID-19 vaccine mandates in 2021. The VA was the first federal agency to implement a mandate.

President Biden rescinded the mandates in May 2023, citing a drop in COVID-19 cases and hospitalizations. His administration maintains the choice to require vaccines was the right one and saved lives.

“Our administration’s vaccination requirements helped ensure the safety of workers in critical workforces including those in the healthcare and education sectors, protecting themselves and the populations they serve, and strengthening their ability to provide services without disruptions to operations,” the White House said.

Some experts said requiring vaccination meant many younger people were forced to get a vaccine despite the risks potentially outweighing the benefits, leaving fewer doses for older adults.

By mandating the vaccines to younger people and those with natural immunity from having had COVID, older people in the U.S. and other countries did not have access to them, and many people might have died because of that,” Martin Kulldorff, a professor of medicine on leave from Harvard Medical School, told The Epoch Times previously.

The VA was one of just a handful of agencies to keep its mandate in place following the removal of many federal mandates.

“At this time, the vaccine requirement will remain in effect for VA health care personnel, including VA psychologists, pharmacists, social workers, nursing assistants, physical therapists, respiratory therapists, peer specialists, medical support assistants, engineers, housekeepers, and other clinical, administrative, and infrastructure support employees,” Mr. McDonough wrote to VA employees at the time.

This also includes VA volunteers and contractors. Effectively, this means that any Veterans Health Administration (VHA) employee, volunteer, or contractor who works in VHA facilities, visits VHA facilities, or provides direct care to those we serve will still be subject to the vaccine requirement at this time,” he said. “We continue to monitor and discuss this requirement, and we will provide more information about the vaccination requirements for VA health care employees soon. As always, we will process requests for vaccination exceptions in accordance with applicable laws, regulations, and policies.”

The version of the shots cleared in the fall of 2022, and available through the fall of 2023, did not have any clinical trial data supporting them.

A new version was approved in the fall of 2023 because there were indications that the shots not only offered temporary protection but also that the level of protection was lower than what was observed during earlier stages of the pandemic.

Ms. Manookian, whose group has challenged several of the federal mandates, said that the mandate “illustrates the dangers of the administrative state and how these federal agencies have become a law unto themselves.”

Tyler Durden Sat, 03/09/2024 - 22:10

Read More

Continue Reading

Trending